Norges Bank’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-34,044
Closed -$507K 1828
2024
Q4
$507K Sell
34,044
-43,080
-56% -$704K ﹤0.01% 1792
2024
Q3
$1.18M Buy
77,124
+65,150
+544% +$1.03M ﹤0.01% 1718
2024
Q2
$182K Sell
11,974
-67,850
-85% -$1.1M ﹤0.01% 1918
2024
Q1
$1.51M Hold
79,824
﹤0.01% 1761
2023
Q4
$1.52M Hold
79,824
﹤0.01% 1821
2023
Q3
$1.43M Hold
79,824
﹤0.01% 1859
2023
Q2
$1.62M Hold
79,824
﹤0.01% 1888
2023
Q1
$1.46M Buy
79,824
+47,998
+151% +$917K ﹤0.01% 1961
2022
Q4
$658K Sell
31,826
-122,000
-79% -$3.36M ﹤0.01% 2082
2022
Q3
$4.02M Buy
153,826
+15,521
+11% +$410K ﹤0.01% 1803
2022
Q2
$3.5M Buy
+138,305
New +$3.39M ﹤0.01% 1827
2021
Q3
Sell
-20,000
Closed -$549K 2332
2021
Q2
$549K Hold
20,000
﹤0.01% 2160
2021
Q1
$562K Hold
20,000
﹤0.01% 2083
2020
Q4
$519K Hold
20,000
﹤0.01% 2076
2020
Q3
$343K Buy
+20,000
New +$447K ﹤0.01% 2098
2018
Q2
Sell
-30,000
Closed -$463K 2161
2018
Q1
$463K Buy
+30,000
New +$500K ﹤0.01% 2094

Other funds holding RCUS

Norges Bank's RCUS Position: Q1 2025 in Review

Norges Bank sold out of Arcus Biosciences (RCUS) in Q1 2025, closing a stake of 34,044 shares — an estimated $507K sold.

Norges Bank first reported a position in RCUS in Q1 2018 and held it in 16 quarters. The position peaked at $4.02M in Q3 2022. 186 funds tracked by Wall St. Rank hold RCUS as of Q1 2025.

  • Norges Bank reported no remaining Arcus Biosciences position as of Q1 2025 after selling out during the quarter.
  • Norges Bank sold 34,044 Arcus Biosciences shares in Q1 2025, an estimated $507K.
  • Norges Bank first reported a position in Arcus Biosciences in Q1 2018 and held it in 16 quarters.
  • Norges Bank's Arcus Biosciences position peaked at $4.02M in Q3 2022.
  • 186 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2025.

Based on Norges Bank's 13F filing for Q1 2025, filed 13 May 2025.